Define the strategic vision for 2020-2024
Reshape cultural values based on the spirit of combating the COVID-19 pandemic
In 2020, DIAN Identification Virtual Autopsy Research Centre established and successfully developed a complete program of virtual autopsy technology，Diangio & Aiangio

In 2019, DIAN DIAGNOSTICS participated in the establishment of Zhejiang Laboratory and Testing Sharing Platform Specialty Alliance and Zhejiang Pathology Specialty Alliance
In 2018, Digena mass spectrometry platform established for metabonomics
In 2017, CALIBRA Precision Medicine established for nucleic acid analysis

In 2014, DIAN Healthcare (One-stop healthcare management service organization)
and DIAN Biotechnology (IVD products manufacturing) founded
In 2011, DIAN DIAGNOSTICS listed on GEM of Shenzhen Stock Exchange (300244)

In 2008, DIAN DIAGNOSTICS obtained qualification of forensics and established DIAN FORENSICS SCIENCE CO., LTD.
In 2007, Nanjing DIAN Medical Laboratory established, opening the path to a nationwide laboratory chain network
In 2004, the first independent medical laboratory officially established

In 1996, DIAN DIAGNOSTICS launched PCR (molecular diagnosis)
In 1999, DIAN DIAGNOSTICS strategic cooperation with Roche Diagnostics